T J Matthews|C F Reich - JoVE Visualize

Showing results (101-110 of 161) with videos related to

Pageof 17

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989

HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infectionK J Weinhold, H K Lyerly, S D Stanley, et al.

Virology|May 18, 1999

Engineering of noninfectious HIV-1-like particles containing mutant gp41 glycoproteins as vaccine candidates that allow vaccinees to be distinguished from HIV-1 infecteesB Rovinski, G A Dekaban, S X Cao, et al.

AIDS Research and Human Retroviruses|June 1, 1988

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoproteinM A Skinner, R Ting, A J Langlois, et al.

The Journal of Experimental Medicine|August 1, 1988

Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell linesS Chaffee, J M Leeds, T J Matthews, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991

Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4M Ivey-Hoyle, J S Culp, M A Chaikin, et al.

American Journal of Hematology|May 1, 1988

Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM L Smiley, G C White, P Becherer, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domainN E Richardson, N R Brown, R E Hussey, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimenM J McElrath, L Corey, P D Greenberg, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989

GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibodyD S Tyler, C L Nastala, S D Stanley, et al.

Blood|March 1, 1991

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donorsL M Cummins, K J Weinhold, T J Matthews, et al.

Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:

Pageof 17

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989

HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infectionK J Weinhold, H K Lyerly, S D Stanley, et al.

Virology|May 18, 1999

Engineering of noninfectious HIV-1-like particles containing mutant gp41 glycoproteins as vaccine candidates that allow vaccinees to be distinguished from HIV-1 infecteesB Rovinski, G A Dekaban, S X Cao, et al.

AIDS Research and Human Retroviruses|June 1, 1988

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoproteinM A Skinner, R Ting, A J Langlois, et al.

The Journal of Experimental Medicine|August 1, 1988

Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell linesS Chaffee, J M Leeds, T J Matthews, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991

Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4M Ivey-Hoyle, J S Culp, M A Chaikin, et al.

American Journal of Hematology|May 1, 1988

Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM L Smiley, G C White, P Becherer, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988

Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domainN E Richardson, N R Brown, R E Hussey, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimenM J McElrath, L Corey, P D Greenberg, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989

GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibodyD S Tyler, C L Nastala, S D Stanley, et al.

Blood|March 1, 1991

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donorsL M Cummins, K J Weinhold, T J Matthews, et al.

Pageof 17